After sales languished for quite a while once it reached a peak of $200mn., this Redwood City company was dangerously close to being a sweet acquisition. In an attempt to stave this off, it went off on its own to try and appear larger than itself. This obviously hadn't paid off - if you observe their stagnant sales and stock.
So now, they seem to have finally given up the hopes of going it alone. They already have a partnership with ev3, so this marriage should not be so unfamiliar.
But will it pay off?
There have been quite a few ups and downs - the previous CEO left all too suddenly and quietly one day, the VP of sales left unable to push sales upwards, the strategy for NightHawk, one of their next generation products changed all of a sudden. Their other R&D efforts are yet to pay off..And then there is the somewhat questionable acquisition of Kerberos.... this is definitely one medical device company to watch and see if it can pick itself up...!
Add to Onlywire
No comments:
Post a Comment